As of 2025-07-05, the Relative Valuation of FibroGen Inc (FGEN) is (57.08) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.61 USD, the upside of FibroGen Inc based on Relative Valuation is -1117.5%.
The range of the Relative Valuation is (46.19) - (63.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 24.2x | 20.0x |
| Forward P/E multiples | 17.5x - 28.9x | 23.2x |
| Fair Price | (46.19) - (63.93) | (57.08) |
| Upside | -923.4% - -1239.6% | -1117.5% |
| Date | P/E |
| 2025-07-03 | -2.13 |
| 2025-07-02 | -1.99 |
| 2025-07-01 | -2.00 |
| 2025-06-30 | -2.01 |
| 2025-06-27 | -1.98 |
| 2025-06-26 | -2.01 |
| 2025-06-25 | -2.16 |
| 2025-06-24 | -2.06 |
| 2025-06-23 | -2.05 |
| 2025-06-20 | -2.18 |
| 2025-06-18 | -1.95 |
| 2025-06-17 | -2.23 |
| 2025-06-16 | -2.52 |
| 2025-06-13 | -2.50 |
| 2025-06-12 | -2.92 |
| 2025-06-11 | -2.93 |
| 2025-06-10 | -2.93 |
| 2025-06-09 | -3.03 |
| 2025-06-06 | -2.97 |
| 2025-06-05 | -2.89 |
| 2025-06-04 | -2.89 |
| 2025-06-03 | -2.85 |
| 2025-06-02 | -2.78 |
| 2025-05-30 | -2.72 |
| 2025-05-29 | -3.01 |
| 2025-05-28 | -3.01 |
| 2025-05-27 | -3.04 |
| 2025-05-23 | -3.13 |
| 2025-05-22 | -3.11 |
| 2025-05-21 | -3.14 |
| 2025-05-20 | -3.26 |
| 2025-05-19 | -2.97 |
| 2025-05-16 | -2.90 |
| 2025-05-15 | -2.86 |
| 2025-05-14 | -2.84 |
| 2025-05-13 | -2.83 |
| 2025-05-12 | -2.89 |
| 2025-05-09 | -2.92 |
| 2025-05-08 | -3.02 |
| 2025-05-07 | -3.09 |
| 2025-05-06 | -2.76 |
| 2025-05-05 | -3.01 |
| 2025-05-02 | -3.16 |
| 2025-05-01 | -3.21 |
| 2025-04-30 | -3.20 |
| 2025-04-29 | -3.10 |
| 2025-04-28 | -3.08 |
| 2025-04-25 | -2.97 |
| 2025-04-24 | -3.03 |
| 2025-04-23 | -2.90 |